Role of telomeres and telomerase in cancer

Seminars in Cancer Biology

Volumn 21, Issue 6, 2011, Pages 349-353

  Shay, Jerry W ^a   Wright, Woodring E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Aging; DNA damage; Evolutionary considerations; Immortalization; Replicative senescence; Stem cells

Indexed keywords

BEVACIZUMAB; IMETELSTAT; TELOMERASE;

ADVANCED CANCER; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER GENE THERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CELL AGING; CELL DIVISION; CELL PROLIFERATION; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; DRUG EFFICACY; ENZYME ACTIVITY; GENOMIC INSTABILITY; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; NEOPLASM; PANCREAS CANCER; REVIEW; TARGET CELL DESTRUCTION; TELOMERE;

HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; TELOMERASE; TELOMERE;

EID: 82755192899     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2011.10.001     Document Type: Review

References (32)

1. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25:585-662.
2. Hayflick L. How and why we age. Exp Gerontol 1998, 33:639-665.
3. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965, 37:614-636.
4. Hayflick L. The coming of age of WI-38. Adv Cell Cult 1984, 3:303-316.
5. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
6. Shay J.W., Wright W.E., Werbin H. Defining the molecular mechanism of human cell immortalization. Biochim Biophys Acta 1991, 1072:1-7.
7. Kim N.W., Pietyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
8. Collins K., Mitchell J.R. Telomerase in the human organism. Oncogene 2002, 21:564-579.
9. Moyzis R.K., Buckingham J.M., Cram L.S., Dani M., Deaven L.L., Jones M.D., et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988, 85:6622-6626.
10. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005, 19:2100-2110.
11. de Lange T. T-loop and the origin of telomeres. Nat Rev Mol Cell Biol 2004, 5(4):323-329.
12. Shay J.W. Telomerase therapeutics: telomeres recognized as a DNA damage signal. Clin Cancer Res 2003, 9:3521-3525.
13. Wright W.E., Shay J.W. The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 1992, 27:383-389.
14. Wright W.E., Shay J.W. Time, telomeres and tumors: is cellular senescence more than an anticancer mechanism?. Trends Cell Biol 1995, 5(8):293-297.
15. Shay J.W. Aging and cancer: are telomeres and telomerase the connection?. Mol Med Today 1995, 1(8):378-384.
16. Harley C.B. Telomere loss: mitotic clock or genetic time bomb?. Mutat Res 1991, 256:271-282.
17. Wright W.E., Pereira-Smith O.M., Shay J.W. Reversible cellular senescence: a two-stage model for the immortalization of normal human diploid fibroblasts. Mol Cell Biol 1989, 9:3088-3092.
18. Langford L.A., Piatyszek M.A., Xu R.S., Schold S.C., Wright W.E., Shay J.W. Telomerase activity in ordinary meningiomas predicts poor outcome. Human Pathol 1997, 28(4):416-420.
19. Roig A.I., Wright W.E., Shay J.W. Is telomerase a novel target for metastatic colon cancer?. Curr Colorectal Cancer Rep 2009, 5:203-208.
20. Shay J.W., Keith W.N. Cellular immortality and cancer: from telomerase to cancer stem cells. BBA Mol Basis Dis 2009, 1792:227-228.
21. Buseman CM, Wright WE, Shay JW. Is telomerase a viable target in cancer? Mut Res, in press.
22. Hanahan D., Weinberg R. The hallmarks of cancer. Cell 2000, 100:57-70.
23. Shay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997, 33:787-791.
24. Marian C.O., Cho S.K., Hatanpaa K.J., Wright W.E., Maher E., Madden C., et al. The telomerase inhibitor GRN163L blocks telomerase activity, induces telomere attrition and limits GBM stem cell proliferation and in-vivo growth. Clin Cancer Res 2010, 16:154-163.
25. Marian C.O., Wright W.E., Shay J.W. The effect of telomerase inhibition on prostate tumor-initiating cells. Int J Cancer 2010, 127:321-331.
26. Hiyama K., Hiyama E., Shay J.W. Telomeres and telomerase in humans, Chapter 1. Cancer Drug Discovery and Development 2009, 3-21. Springer Press. K. Hiyama (Ed.).
27. Morales C.P., Holt S.E., Ouellette M., Kaur K.J., Wilson K.S., White M.A., et al. Lack of cancer-associated changes in human fibroblasts after immortalization with telomerase. Nat Genet 1999, 21:115-118.
28. Davoli T., Denchi E.L., de Lange T. Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 2010, 141:81-93.
29. Potten C.S., Morris R.J. Epithelial stem cells in vivo. J Cell Sci 1988, 10(Suppl.):45-62.
30. Gomes N.M., Shay J.W., Wright W.E. Telomere biology in Metazoa. FEBS Lett 2010, 584:3741-3751.
31. Gomes N.M.V., Ryder O.A., Houck M.L., Charter S.J., Walker W., Forsyth N.R., et al. Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination. Aging Cell 2011, 10(5):761-768. 10.1111/j.1474-9726.2011.00718.x.
32. Wright W.E., Shay J.W. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med 2000, 6:849-851.